QELBREE
Live / Registered — Registered (as of 16 Nov 2021)
What this means for you
Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88696469
- Registration number
- 6563462
- Mark type
- Stylized text
- Filed
- 18 Nov 2019
- Published for opposition
- 26 May 2020
- Registered
- 16 Nov 2021
- Attorney of record
- Mark D Simpson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Owner
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
Prosecution history
- 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 14 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Aug 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Jul 2021 — USE AMENDMENT FILED
- 02 Aug 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jul 2021 — TEAS STATEMENT OF USE RECEIVED
- 23 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2021 — SOU EXTENSION 1 GRANTED
- 21 Jan 2021 — SOU EXTENSION 1 FILED
- 21 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 21 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 May 2020 — PUBLISHED FOR OPPOSITION
- 06 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED